Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension

Arterial hypertension is a risk factor for several pathologies, mainly including cardio-cerebrovascular diseases, which rank as leading causes of morbidity and mortality worldwide. Arterial hypertension also constitutes a fundamental component of the metabolic syndrome. <i>Helicobacter pylori&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jannis Kountouras, Apostolis Papaefthymiou, Stergios A. Polyzos, Georgia Deretzi, Elisabeth Vardaka, Elpidoforos S. Soteriades, Maria Tzitiridou-Chatzopoulou, Paraskevas Gkolfakis, Kyriaki Karafyllidou, Michael Doulberis
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c733d212b5bf450cb4882cecd4722055
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c733d212b5bf450cb4882cecd4722055
record_format dspace
spelling oai:doaj.org-article:c733d212b5bf450cb4882cecd47220552021-11-25T18:25:21ZImpact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension10.3390/microorganisms91123512076-2607https://doaj.org/article/c733d212b5bf450cb4882cecd47220552021-11-01T00:00:00Zhttps://www.mdpi.com/2076-2607/9/11/2351https://doaj.org/toc/2076-2607Arterial hypertension is a risk factor for several pathologies, mainly including cardio-cerebrovascular diseases, which rank as leading causes of morbidity and mortality worldwide. Arterial hypertension also constitutes a fundamental component of the metabolic syndrome. <i>Helicobacter pylori</i> infection is one of the most common types of chronic infection globally and displays a plethora of both gastric and extragastric effects. Among other entities, <i>Helicobacter pylori</i> has been implicated in the pathogenesis of the metabolic syndrome. Within this review, we illustrate the current state-of-the-art evidence, which may link several components of the <i>Helicobacter pylori</i>-related metabolic syndrome, including non-alcoholic fatty liver disease and arterial hypertension. In particular, current knowledge of how <i>Helicobacter pylori</i> exerts its virulence through dietary, inflammatory and metabolic pathways will be discussed. Although there is still no causative link between these entities, the emerging evidence from both basic and clinical research supports the proposal that several components of the <i>Helicobacter pylori</i> infection-related metabolic syndrome present an important risk factor in the development of arterial hypertension. The triad of <i>Helicobacter pylori</i> infection, the metabolic syndrome, and hypertension represents a crucial worldwide health problem on a pandemic scale with high morbidity and mortality, like COVID-19, thereby requiring awareness and appropriate management on a global scale.Jannis KountourasApostolis PapaefthymiouStergios A. PolyzosGeorgia DeretziElisabeth VardakaElpidoforos S. SoteriadesMaria Tzitiridou-ChatzopoulouParaskevas GkolfakisKyriaki KarafyllidouMichael DoulberisMDPI AGarticle<i>Helicobacter pylori</i>metabolic syndromeatherosclerosisnon-alcoholic fatty liver diseasearterial hypertensiondietBiology (General)QH301-705.5ENMicroorganisms, Vol 9, Iss 2351, p 2351 (2021)
institution DOAJ
collection DOAJ
language EN
topic <i>Helicobacter pylori</i>
metabolic syndrome
atherosclerosis
non-alcoholic fatty liver disease
arterial hypertension
diet
Biology (General)
QH301-705.5
spellingShingle <i>Helicobacter pylori</i>
metabolic syndrome
atherosclerosis
non-alcoholic fatty liver disease
arterial hypertension
diet
Biology (General)
QH301-705.5
Jannis Kountouras
Apostolis Papaefthymiou
Stergios A. Polyzos
Georgia Deretzi
Elisabeth Vardaka
Elpidoforos S. Soteriades
Maria Tzitiridou-Chatzopoulou
Paraskevas Gkolfakis
Kyriaki Karafyllidou
Michael Doulberis
Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
description Arterial hypertension is a risk factor for several pathologies, mainly including cardio-cerebrovascular diseases, which rank as leading causes of morbidity and mortality worldwide. Arterial hypertension also constitutes a fundamental component of the metabolic syndrome. <i>Helicobacter pylori</i> infection is one of the most common types of chronic infection globally and displays a plethora of both gastric and extragastric effects. Among other entities, <i>Helicobacter pylori</i> has been implicated in the pathogenesis of the metabolic syndrome. Within this review, we illustrate the current state-of-the-art evidence, which may link several components of the <i>Helicobacter pylori</i>-related metabolic syndrome, including non-alcoholic fatty liver disease and arterial hypertension. In particular, current knowledge of how <i>Helicobacter pylori</i> exerts its virulence through dietary, inflammatory and metabolic pathways will be discussed. Although there is still no causative link between these entities, the emerging evidence from both basic and clinical research supports the proposal that several components of the <i>Helicobacter pylori</i> infection-related metabolic syndrome present an important risk factor in the development of arterial hypertension. The triad of <i>Helicobacter pylori</i> infection, the metabolic syndrome, and hypertension represents a crucial worldwide health problem on a pandemic scale with high morbidity and mortality, like COVID-19, thereby requiring awareness and appropriate management on a global scale.
format article
author Jannis Kountouras
Apostolis Papaefthymiou
Stergios A. Polyzos
Georgia Deretzi
Elisabeth Vardaka
Elpidoforos S. Soteriades
Maria Tzitiridou-Chatzopoulou
Paraskevas Gkolfakis
Kyriaki Karafyllidou
Michael Doulberis
author_facet Jannis Kountouras
Apostolis Papaefthymiou
Stergios A. Polyzos
Georgia Deretzi
Elisabeth Vardaka
Elpidoforos S. Soteriades
Maria Tzitiridou-Chatzopoulou
Paraskevas Gkolfakis
Kyriaki Karafyllidou
Michael Doulberis
author_sort Jannis Kountouras
title Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
title_short Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
title_full Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
title_fullStr Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
title_full_unstemmed Impact of <i>Helicobacter pylori</i>-Related Metabolic Syndrome Parameters on Arterial Hypertension
title_sort impact of <i>helicobacter pylori</i>-related metabolic syndrome parameters on arterial hypertension
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c733d212b5bf450cb4882cecd4722055
work_keys_str_mv AT janniskountouras impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT apostolispapaefthymiou impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT stergiosapolyzos impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT georgiaderetzi impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT elisabethvardaka impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT elpidoforosssoteriades impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT mariatzitiridouchatzopoulou impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT paraskevasgkolfakis impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT kyriakikarafyllidou impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
AT michaeldoulberis impactofihelicobacterpyloriirelatedmetabolicsyndromeparametersonarterialhypertension
_version_ 1718411223534403584